European Union (EU) commissioners will approve the agreement on Wednesday, Erik Meimer said at a press conference in Brussels.
–
“Negotiations with the pharmaceutical industry are over,” a source told the news agency before the official statement to the news agency.
–
The EC has been negotiating with Pfizer and BioNTech for several months.
–
Following initial negotiations, the EC confirmed in September that it planned to provide up to 300 million doses of vaccine from these developers.
–
Pfizer and BioNTech said on Monday that their jointly developed new coronavirus vaccine had shown 90% effectiveness against Covid-19 infection in a third phase of trials.
–
Both companies said they could ask the US Food and Drug Administration (FDA) for permission to use the vaccine next week.
–
Germany will have access to 100 million doses of the vaccine as soon as the drug is approved by the regulator, German Health Minister Jens Span said on Tuesday.
–
The EC is expected to sign an agreement with the companies soon, the minister said.
–
“Be calm, we will bring it to an early conclusion,” he added.
— .
